These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 25066223)

  • 1. Metacognitive group training for schizophrenia spectrum patients with delusions: a randomized controlled trial.
    van Oosterhout B; Krabbendam L; de Boer K; Ferwerda J; van der Helm M; Stant AD; van der Gaag M
    Psychol Med; 2014 Oct; 44(14):3025-35. PubMed ID: 25066223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms.
    Moritz S; Veckenstedt R; Randjbar S; Vitzthum F; Woodward TS
    Psychol Med; 2011 Sep; 41(9):1823-32. PubMed ID: 21275083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing self-reported cognitive biases and increasing clinical insight through meta-cognitive training in patients with chronic schizophrenia.
    Gawęda Ł; Krężołek M; Olbryś J; Turska A; Kokoszka A
    J Behav Ther Exp Psychiatry; 2015 Sep; 48():98-104. PubMed ID: 25775947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia.
    Moritz S; Veckenstedt R; Bohn F; Hottenrott B; Scheu F; Randjbar S; Aghotor J; Köther U; Woodward TS; Treszl A; Andreou C; Pfueller U; Roesch-Ely D
    Schizophr Res; 2013 Dec; 151(1-3):61-9. PubMed ID: 24183707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis.
    Freeman D; Dunn G; Startup H; Pugh K; Cordwell J; Mander H; Černis E; Wingham G; Shirvell K; Kingdon D
    Lancet Psychiatry; 2015 Apr; 2(4):305-13. PubMed ID: 26360083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metacognitive training for schizophrenia: a multicentre randomised controlled trial.
    Briki M; Monnin J; Haffen E; Sechter D; Favrod J; Netillard C; Cheraitia E; Marin K; Govyadovskaya S; Tio G; Bonin B; Chauvet-Gelinier JC; Leclerc S; Hodé Y; Vidailhet P; Berna F; Bertschy AZ; Vandel P
    Schizophr Res; 2014 Aug; 157(1-3):99-106. PubMed ID: 24972754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
    Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
    JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metacognitive training (MCT) for schizophrenia improves cognitive insight: a randomized controlled trial in a Chinese sample with schizophrenia spectrum disorders.
    Lam KC; Ho CP; Wa JC; Chan SM; Yam KK; Yeung OS; Wong WC; Balzan RP
    Behav Res Ther; 2015 Jan; 64():38-42. PubMed ID: 25513971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of metacognitive training for patients with schizophrenia: a narrative systematic review of studies published between 2009 and 2015.
    Pankowski D; Kowalski J; Gawęda Ł
    Psychiatr Pol; 2016; 50(4):787-803. PubMed ID: 27847929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis: A Randomized Clinical Trial.
    Balzan RP; Mattiske JK; Delfabbro P; Liu D; Galletly C
    Schizophr Bull; 2019 Jan; 45(1):27-36. PubMed ID: 30376124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for the efficacy of a metacognitive group training in schizophrenia.
    Moritz S; Kerstan A; Veckenstedt R; Randjbar S; Vitzthum F; Schmidt C; Heise M; Woodward TS
    Behav Res Ther; 2011 Mar; 49(3):151-7. PubMed ID: 21276962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the efficacy and feasibility of providing metacognitive training for patients with schizophrenia by mental health nurses: A randomized controlled trial.
    de Pinho LMG; Sequeira CADC; Sampaio FMC; Rocha NB; Ozaslan Z; Ferre-Grau C
    J Adv Nurs; 2021 Feb; 77(2):999-1012. PubMed ID: 33222210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized metacognitive therapy program for patients with psychosis (MCT+): introduction of a novel approach for psychotic symptoms.
    Vitzthum FB; Veckenstedt R; Moritz S
    Behav Cogn Psychother; 2014 Jan; 42(1):105-10. PubMed ID: 23631928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study.
    Favrod J; Rexhaj S; Bardy S; Ferrari P; Hayoz C; Moritz S; Conus P; Bonsack C
    Eur Psychiatry; 2014 Jun; 29(5):275-81. PubMed ID: 24176646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trial.
    Schneider BC; Brüne M; Bohn F; Veckenstedt R; Kolbeck K; Krieger E; Becker A; Drommelschmidt KA; Englisch S; Eisenacher S; Lee-Grimm SI; Nagel M; Zink M; Moritz S
    BMC Psychiatry; 2016 Feb; 16():51. PubMed ID: 26921116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of metacognitive training on delusion severity and metacognitive ability in schizophrenia.
    Erawati E; Keliat BA; Helena N; Hamid A
    J Psychiatr Ment Health Nurs; 2014; 21(9):841-7. PubMed ID: 24548341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized metacognitive therapy for delusions: A randomized controlled rater-blind study.
    Andreou C; Wittekind CE; Fieker M; Heitz U; Veckenstedt R; Bohn F; Moritz S
    J Behav Ther Exp Psychiatry; 2017 Sep; 56():144-151. PubMed ID: 27919404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metacognitive training for patients with schizophrenia: preliminary evidence for a targeted, single-module programme.
    Balzan RP; Delfabbro PH; Galletly CA; Woodward TS
    Aust N Z J Psychiatry; 2014 Dec; 48(12):1126-36. PubMed ID: 24159051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized control trial to assess the efficacy of metacognitive training compared with a psycho-educational group in people with a recent-onset psychosis.
    Ochoa S; López-Carrilero R; Barrigón ML; Pousa E; Barajas A; Lorente-Rovira E; González-Higueras F; Grasa E; Ruiz-Delgado I; Cid J; Birulés I; Esteban-Pinos I; Casañas R; Luengo A; Torres-Hernández P; Corripio I; Montes-Gámez M; Beltran M; De Apraiz A; Domínguez-Sánchez L; Sánchez E; Llacer B; Pélaez T; Bogas JL; Moritz S;
    Psychol Med; 2017 Jul; 47(9):1573-1584. PubMed ID: 28166848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of extended metacognitive training for psychosis: A randomized controlled trial.
    Ishikawa R; Ishigaki T; Shimada T; Tanoue H; Yoshinaga N; Oribe N; Morimoto T; Matsumoto T; Hosono M
    Schizophr Res; 2020 Jan; 215():399-407. PubMed ID: 31471248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.